What Tissue Biopsies Are Evaluated For in Reflux and Erosive Esophagitis
Biopsies taken during endoscopy for reflux or erosive esophagitis are primarily evaluated for Barrett's esophagus (when salmon-colored mucosa is present), and secondarily for microscopic esophagitis features including basal cell hyperplasia, papillary elongation, inflammatory cell infiltration (neutrophils, eosinophils), and dilated intercellular spaces—though routine biopsy is NOT recommended for typical erosive esophagitis cases.
Primary Indication: Barrett's Esophagus Surveillance
The most important reason to biopsy in GERD/erosive esophagitis patients is to detect Barrett's esophagus 1, 2:
- When to biopsy: Only when salmon-colored mucosa extends ≥1 cm above the gastric folds (best examined after gastric decompression)
- Protocol: Four-quadrant biopsies every 1-2 cm of Barrett's mucosa (Seattle protocol), plus targeted biopsies of any mucosal abnormalities 2
- Classification: Grade according to Prague classification when present 1
Critical caveat: Do NOT routinely biopsy a normal or irregular Z-line 2. This is a common pitfall that leads to unnecessary procedures and costs.
Secondary Consideration: Microscopic Esophagitis (Limited Clinical Utility)
While histological changes can be seen in GERD, routine biopsy for diagnosis of erosive esophagitis is NOT recommended because:
Histological Features That May Be Present:
When biopsies are taken (typically 2-4 cm above the gastroesophageal junction), pathologists evaluate for:
- Basal cell hyperplasia (>15% of epithelial thickness)
- Papillary elongation (>66% of epithelial thickness)
- Inflammatory infiltration: neutrophils, eosinophils, lymphocytes
- Dilated intercellular spaces (DIS)
- Necrosis/erosion (in severe cases)
Why These Findings Have Limited Value:
The evidence is contradictory but leans toward limited utility:
- Low sensitivity: Studies show only 30-46% sensitivity for diagnosing GERD 3, 4
- Adequate specificity: 74-78% 5, 3
- Better in NERD than erosive disease: Histology may help in non-erosive reflux disease (70-84% positive findings) 6, 7, but if you already see erosions endoscopically, you've already confirmed reflux disease
- No additional value over clinical assessment: Histology doesn't change management when erosive esophagitis is visible 3
Practical Algorithm for Biopsy Decisions
DO Biopsy When:
- Salmon-colored mucosa ≥1 cm above gastric folds → Barrett's surveillance protocol 2
- Suspected eosinophilic esophagitis → At least 6 specimens from distal and mid/proximal esophagus 2
DO NOT Routinely Biopsy When:
- Visible erosive esophagitis (LA grade B-D) → Diagnosis is already confirmed endoscopically 1
- Normal-appearing Z-line or irregular Z-line → Low yield, not cost-effective 2
- Non-erosive reflux disease → Consider pH monitoring instead; histology has poor sensitivity 1
Important Pitfalls to Avoid
- Over-biopsying: The most common error is taking biopsies when erosive esophagitis is already visible—this adds no diagnostic value and increases costs 3
- Missing Barrett's: Failing to biopsy salmon-colored mucosa is the critical miss, as this has cancer risk implications 1, 2
- Expecting histology to diagnose GERD: Even with multiple biopsy sites, histology cannot reliably confirm or exclude GERD in the absence of erosions 4
- Confusing LA grade A with pathologic reflux: LA grade A esophagitis can be seen in healthy volunteers and doesn't constitute erosive reflux disease 1
The bottom line: Biopsy for Barrett's when indicated, but don't expect routine esophageal biopsies to add diagnostic value in typical erosive esophagitis cases where the endoscopic diagnosis is already apparent.